March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA Imran BabarChief Business Officer at Sudo BioSciencesSpeaker
Profile
Imran is CBO at Sudo Biosciences and serves on the Board for Rare Genomics Institute.Previously, Imran was the CBO of Cydan, an NEA and Pfizer Ventures-backed orphan drug accelerator. He is also co-founder of several companies including Arvada. Prior to Cydan, Imran was on the venture capital team at OrbiMed Advisors and the biotechnology equity research team at Cowen. Imran is also co-founder of Rare Genomics Institute, a nonprofit dedicated to helping patients with rare diseases.Imran completed his PhD in Molecular Biology at Yale and his BA in Biology at Carleton College.
Agenda Sessions
Innovation station - Rapid Fire Case Studies Directly from the Thought Leaders Innovating in the Rare Disease Space
, 2:30pmView SessionBrain Storming Session - Hot Topic Break Down
, 3:45pmView Session